Literature DB >> 19319132

Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men.

Ida Schoultz1, Deepti Verma, Jonas Halfvarsson, Leif Törkvist, Mats Fredrikson, Urban Sjöqvist, Mikael Lördal, Curt Tysk, Maria Lerm, Peter Söderkvist, Johan D Söderholm.   

Abstract

OBJECTIVES: Crohn's disease (CD) is characterized by overproduction of proinflammatory cytokines like interleukin (IL)-1beta. Production of mature IL-1beta is dependent on a caspase-1-activating protein complex called the NALP3 inflammasome, composed of NALP3, ASC, and CARD8. NALP3 shares structural similarities with Nod2, and both of these proteins are required for bacteria-induced IL-1beta secretion. The combination of the polymorphisms CARD8 (C10X)and NALP3 (Q705K) was recently shown to be associated with rheumatoid arthritis.Our aim was to investigate whether these combined polymorphisms play a role in the susceptibility to CD.
METHODS: The study included 498 CD patients in two cohorts from different regions and 742 control individuals from a Swedish population. DNA was isolated from whole blood. Polymorphisms of (Q705K) NALP3 and (C10X) CARD8, as well as the Nod2 variants, R702W and G908R, were genotyped using the Taqman single nucleotide polymorphism assay. The Nod2 frameshift mutation, L1007fs, was detected by Megabace SNuPe genotyping.
RESULTS: Our results show that men who have both the C10X and Q705K alleles in CARD8 and NALP3, and who express wild-type alleles of Nod2 are at an increased risk of developing CD (odds ratio, OR: 3.40 range: 1.32-8.76); P = 0.011). No association with these polymorphisms was found in women (OR: 0.89 (range: 0.44-1.77); P = 0.74).
CONCLUSIONS: We suggest a role for combined polymorphisms in CARD8 and NALP3 in the development of CD in men, with obvious sex differences in the genetic susceptibility pattern. These findings give further support to the importance of innate immune responses in CD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319132     DOI: 10.1038/ajg.2009.29

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  60 in total

1.  Cross talk between neuroregulatory molecule and monocyte: nerve growth factor activates the inflammasome.

Authors:  Ananya Datta-Mitra; Smriti Kundu-Raychaudhuri; Anupam Mitra; Siba P Raychaudhuri
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 2.  Inflammasomes and intestinal inflammation.

Authors:  N Zmora; M Levy; M Pevsner-Fishcer; E Elinav
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

3.  NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.

Authors:  Simon A Hirota; Jeffrey Ng; Alan Lueng; Maitham Khajah; Ken Parhar; Yan Li; Victor Lam; Mireille S Potentier; Kelvin Ng; Misha Bawa; Donna-Marie McCafferty; Kevin P Rioux; Subrata Ghosh; Ramnik J Xavier; Sean P Colgan; Jurg Tschopp; Daniel Muruve; Justin A MacDonald; Paul L Beck
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

4.  The structure of the CARD8 caspase-recruitment domain suggests its association with the FIIND domain and procaspases through adjacent surfaces.

Authors:  Tengchuan Jin; Mo Huang; Patrick Smith; Jiansheng Jiang; T Sam Xiao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-04-27

5.  [Interleukin-1 cytokines, inflammasomes, NOD-signalosomes and autoinflammation].

Authors:  S D Gadola
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 6.  Genetic and molecular basis of inflammasome-mediated disease.

Authors:  Hal M Hoffman; Susannah D Brydges
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

Review 7.  The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond.

Authors:  Cristina Conforti-Andreoni; Paola Ricciardi-Castagnoli; Alessandra Mortellaro
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

Review 8.  Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis.

Authors:  Maayan Levy; Christoph A Thaiss; Meirav N Katz; Jotham Suez; Eran Elinav
Journal:  Semin Immunopathol       Date:  2014-10-15       Impact factor: 9.623

9.  Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.

Authors:  Lazaros-Dimitrios Lazaridis; Aikaterini Pistiki; Evangelos J Giamarellos-Bourboulis; Marianna Georgitsi; Georgia Damoraki; Dimitrios Polymeros; George D Dimitriadis; Konstantinos Triantafyllou
Journal:  Dig Dis Sci       Date:  2017-05-18       Impact factor: 3.199

Review 10.  Intestinal barrier in inflammatory bowel disease.

Authors:  Lena Antoni; Sabine Nuding; Jan Wehkamp; Eduard F Stange
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.